ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,712.69
      -0.28%
      US Tech 100
      19,428.79
      -0.35%
      Dow Jones
      41,794.60
      -0.61%
      Brent Oil
      75.06
      -0.07%
      Bitcoin
      67,987.81
      0.25%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Cardiol Therapeutics Inc (CRDL) Quote

      Cardiol Therapeutics Inc

      Cardiol Therapeutics Inc (CRDL)

      Cordel Group Plc
      Cardiol Therapeutics Inc
      1.90
      0.03
      (1.60%)
      Closed November 04 4:00PM
      Delayed by 15 minutes
      1.90
      0.00
      (0.00%)
      After Hours: 6:34PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.90
      Bid
      1.76
      Ask
      1.88
      Volume
      219,664
      1.85 Day's Range 1.92
      0.72 52 Week Range 3.12
      Market Cap
      132.775M
      Previous Close
      1.87
      Open
      1.87
      Last Trade
      1
      @
      1.8786
      Last Trade Time
      Financial Volume
      $ 414,521
      VWAP
      1.8871
      Average Volume (3m)
      425,804
      Shares Outstanding
      69,881,720
      Dividend Yield
      -
      PE Ratio
      -6.56
      Earnings Per Share (EPS)
      -0.4
      Revenue
      -
      Net Profit
      -28.13M

      About Cardiol Therapeutics Inc

      Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solut... Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. Show more

      Sector
      Coml Physical, Biologcl Resh
      Industry
      Coml Physical, Biologcl Resh
      Headquarters
      Oakville, Ontario, Can
      Founded
      -
      Cardiol Therapeutics Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker CRDL. The last closing price for Cardiol Therapeutics was $1.87. Over the last year, Cardiol Therapeutics shares have traded in a share price range of $ 0.72 to $ 3.12.

      Cardiol Therapeutics currently has 69,881,720 shares outstanding. The market capitalization of Cardiol Therapeutics is $130.68 million. Cardiol Therapeutics has a price to earnings ratio (PE ratio) of -6.56.

      Ask ADVFN Intelligence (AI)

      CRDL Latest News

      More News

      FeaturedNorth Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia

      13 hours ago

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      October 22 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      October 11 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      October 10 2024
      Edgar (US Regulatory)

      Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]

      October 09 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      October 09 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      October 08 2024
      Edgar (US Regulatory)

      Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]

      October 08 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      September 24 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      September 10 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.03-1.554404145081.931.941.752389991.83476337CS
      4-0.09-4.522613065331.991.991.566435441.85477583CS
      12-0.11-5.472636815922.012.631.564258041.98572321CS
      26-0.13-6.40394088672.033.121.564469262.1629471CS
      521.05123.5294117650.853.120.723645971.90835337CS
      156-0.74-28.03030303032.643.120.452843701.60666319CS
      260-0.73-27.75665399242.634.960.453300362.05213332CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SPPLSIMPPLE Ltd
      $ 1.18
      (268.75%)
      		401.7M
      NUWENewellis Inc
      $ 2.80
      (105.88%)
      		99.67M
      ADNAdvent Technologies Holdings Inc
      $ 3.34
      (75.79%)
      		64.32M
      STAFStaffing 360 Solutions Inc
      $ 2.8301
      (66.48%)
      		52.45M
      OMICSingular Genomics Systems Inc
      $ 22.28
      (65.53%)
      		320.13k
      TOIIWOncology Institute Inc
      $ 0.0101
      (-47.67%)
      		58.23k
      SSPEW Scripps Company
      $ 2.2701
      (-35.51%)
      		4.25M
      GCTKGlucoTrack Inc
      $ 1.15
      (-33.91%)
      		82.44k
      ILLRTriller Group Inc
      $ 2.86
      (-33.18%)
      		2.32M
      FGFFundamental Global Inc
      $ 15.2501
      (-31.46%)
      		209.53k
      SPPLSIMPPLE Ltd
      $ 1.18
      (268.75%)
      		401.7M
      ELABElevai Labs Inc
      $ 0.0202
      (-30.10%)
      		289.61M
      NVDANVIDIA Corporation
      $ 136.05
      (0.48%)
      		184.49M
      SQQQProShares UltraPro Short QQQ
      $ 7.52
      (1.08%)
      		166.25M
      DJTTrump Media and Technology Group Corporation
      $ 34.34
      (12.37%)
      		119.82M

      CRDL Discussion

      View Posts
      MahinAgency MahinAgency 3 days ago
      NASDAQ: $CRDL is advancing CardiolRx™ for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million

      👍️0
      MahinAgency MahinAgency 3 days ago
      NASDAQ: $CRDL A target of $10 per share (approximately C$13.60) is proposed, indicating a potential upside of over 5x within a year, contingent on strong data readouts for CardiolRx™?
      👍️0
      MahinAgency MahinAgency 4 days ago
      Cardiol Therapeutics sets a 12-month price target of $10, valuing CardiolRx at $9 for recurrent pericarditis and $1 for acute myocarditis, based on projected sales and associated probabilities.
      👍️0
      MahinAgency MahinAgency 4 days ago
      $CRDL Insider Buying: Cardiol CEO David Elsley purchased approximately $100,000 in shares at about $2.03 each
      👍️0
      MahinAgency MahinAgency 5 days ago
      NASDAQ: $CRDL Cardiol Therapeutics sets a 12-month price target of $10, valuing CardiolRx at $9 for recurrent pericarditis and $1 for acute myocarditis, based on projected sales and associated probabilities
      👍️0
      MahinAgency MahinAgency 6 days ago
      NASDAQ: $CRDL 12-month price target is $10, with $9 attributed to recurrent pericarditis and $1 to acute myocarditis

      👍️0
      MahinAgency MahinAgency 6 days ago
      NASDAQ: $CRDL is advancing CardiolRx for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million

      Cardiol sets a 12-month price target of $10
      👍️0
      MahinAgency MahinAgency 1 week ago
      NASDAQ: $CRDL Short Squeeze Allerts 

      A target of $10 per share (approximately C$13.60) is proposed, indicating a potential upside of over 5x within a year, contingent on strong data readouts for CardiolRx™?
      👍️0
      MahinAgency MahinAgency 1 week ago
      Volume looks GOOD 💃💃🚀
      👍️0
      MahinAgency MahinAgency 1 week ago
      NASDAQ: $CRDL Valuation: The 12-month price target is $10, with $9 attributed to recurrent pericarditis and $1 to acute myocarditis

      PICK UP $CRDL THIS MORNING

      👍️0
      MahinAgency MahinAgency 1 week ago
      NASDAQ: $CRDL H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics (CRDL) with a price target of $9.00.

      CardiolRx could serve as an earlier treatment alternative, competing with Arcalyst, which costs $300,000 annually.
      👍️0
      MahinAgency MahinAgency 2 weeks ago
      Cardiol Therapeutics recently reported encouraging outcomes from its Phase II MAvERIC trial of CardiolRx, an ultra-pure oral cannabidiol formulation for recurrent pericarditis. Key highlights include:

      Pain Reduction: Average pain intensity decreased significantly from 5.8 to 2.1 on an 11-point scale after eight weeks.
      C-Reactive Protein (CRP) Levels: Marked reduction in inflammation, comparable to Kiniksa’s rilonacept from the Phase III RHAPSODY trial.
      👍️0
      MahinAgency MahinAgency 2 weeks ago
      $CRDL CEO Investment: Cardiol CEO David Elsley purchased approximately $100,000 in shares at about $2.03 each, indicating strong personal conviction in the company's potential.
      👍️0
      MahinAgency MahinAgency 2 weeks ago
      $CRDL Financial Strategy: With about $21 million in cash, the company may consider a small capital raise if new data boosts the stock price, aiming for a target of $10 per share (C$13.60
      👍️0
      MahinAgency MahinAgency 2 weeks ago
      ARCHER trial (acute myocarditis) completed enrollment, with results expected in Q1 2025. Orphan status could lead to $120M peak sales.
      👍️0
      MahinAgency MahinAgency 2 weeks ago
      NASDAQ: $CRDL Promising clinical progress: Ongoing Phase II trials for myocarditis and pericarditis, with major data expected November 2024

      Time to Add $CRDL Big wave coming
      👍️0
      MahinAgency MahinAgency 2 weeks ago
      NASDAQ: $CRDL is advancing CardiolRx for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million, with key trial results due in November 2024?
      👍️0
      MahinAgency MahinAgency 2 weeks ago
      NASDAQ: $CRDL is advancing CardiolRx for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million, with key trial results due in November 2024?
      👍️0
      MahinAgency MahinAgency 2 weeks ago
      Cardiol Therapeutics (NASDAQ: CRDL) is starting the MAVERIC-2 trial to test CardiolRx™ for recurrent pericarditis, targeting patients discontinuing IL-1 blocker therapy. Positive earlier trial results will be presented in November 2024
      👍️0
      Monksdream Monksdream 2 weeks ago
      CRDL under $2
      👍️0
      williams45 williams45 3 months ago
      Cardiol Therapeutics Inc. ($CRDL) is a clinical-stage life sciences company specializing in anti-inflammatory and anti-fibrotic therapies for heart disease. Its lead candidate, CardiolRx™ (cannabidiol), is in clinical development with a 52-week trading range of $0.661 to $3.12.
      👍️0
      Monksdream Monksdream 3 months ago
      CRDL under $3
      👍️0
      jobynimble jobynimble 4 months ago
      CRDL grabbed some July19 2.50 calls at a nickel, lotto play, chart looking better…
      👍️0
      Tiger Money Tiger Money 4 months ago
      Good!
      👍️0
      Sirpeter Sirpeter 4 months ago
      Higher lows...still bullish
      👍️0
      Tiger Money Tiger Money 4 months ago
      I like!
      👍️0
      Sirpeter Sirpeter 4 months ago
      >$4 likely
      👍️0
      Tiger Money Tiger Money 4 months ago
      Back to $3?
      👍️0
      Sirpeter Sirpeter 4 months ago
      There's volume...looks like run will continue
      👍️0
      Sirpeter Sirpeter 4 months ago
      Yeah...we need to keep plenty of rainy day cash in the jar lol
      👍️0
      Tiger Money Tiger Money 4 months ago
      Tough week, no doubt
      👍️0
      Sirpeter Sirpeter 4 months ago
      My portfolio is in a depression at the moment...may have to eat dirt ala mode for dinner tonight
      👍️0
      Tiger Money Tiger Money 4 months ago
      There will not be one until after they submit which wu probably be around $1-$1.50 area
      👍️0
      Sirpeter Sirpeter 4 months ago
      RGDL too high too fast...will wait on pullback
      👍️0
      Sirpeter Sirpeter 4 months ago
      Will look at it...watch CDRL go lower now that I text you...I bet I jinxed it lol
      🤪 1
      Tiger Money Tiger Money 4 months ago
      Nice. $RDGL about to go up big time!
      👍️0
      Sirpeter Sirpeter 4 months ago
      Morning...there are signs this is stablizing...both my CRDL and WMT calls are green this morning

      Im finding more and more playing options
      are the way to go if careful
      👍️0
      Tiger Money Tiger Money 5 months ago
      No doubt
      👍️0
      Sirpeter Sirpeter 5 months ago
      ...all depends which way the wind blows
      👍️0
      Tiger Money Tiger Money 5 months ago
      It looks excessive but wouldn’t be surprised to see the $1-1.50 range after it run up with $2 being the area it settles in before its first leg up following this downturn
      👍️0
      Sirpeter Sirpeter 5 months ago
      Im thinking they're diluting because they need money for phase 3 trial...otherwise I dont know why the huge sell off
      👍️0
      Sirpeter Sirpeter 5 months ago
      1.50 could be bottom but 1.75 more likely
      👍️0
      Tiger Money Tiger Money 5 months ago
      $1 bid here if my $1.50’s get filled
      👍️0
      Tiger Money Tiger Money 5 months ago
      Nice
      👍️0
      Sirpeter Sirpeter 5 months ago
      I got em...bought 10
      👍️0
      Tiger Money Tiger Money 5 months ago
      Agreed
      👍️0
      Sirpeter Sirpeter 5 months ago
      Nah...it only allows .05 increments...bidding .15...dont want to bid .20...if doesnt fill will let it go and buy something else...tomorrow is a stock mkt holiday and its summer so a weak mkt is expected
      👍️0
      Tiger Money Tiger Money 5 months ago
      Gm- u get filled?
      👍️0
      Sirpeter Sirpeter 5 months ago
      GM... bidding 6/19 2.50 calls @.15
      👍️0
      Tiger Money Tiger Money 5 months ago
      I’m adding about 500-1k a day for the next couple of weeks
      👍️0

      Your Recent History

      NASDAQ
      CRDL
      Cardiol Therapeutics
      NASDAQ
      BWC
      Blue Whale Acquisition C...
      LSE
      SYQ
      BOV
      BHIA3R
      Grupo Casas Bahia ON
      BOV
      BEEF3F
      MINERVA ON
      ASX
      WGN
      Wagners
      COIN
      WARRRRETH
      Wrapped AR
      Delayed Upgrade Clock